Summary

The global Algae Based Omega-3 market is projected to grow from US$ 3367 million in 2025 to US$ 4582 million by 2032, at a CAGR of 4.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Algae Based Omega-3 refers to commercially standardized omega-3 nutritional ingredients derived from microalgae or industrial microalgal production systems, with docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), or combined EPA+DHA as the principal functional lipids. Production typically involves heterotrophic precision fermentation or phototrophic cultivation, followed by biomass harvesting, lipid recovery, refining, deodorization, stabilization and, where required, molecular separation or concentration. Commercial products are supplied mainly as refined algal oils, high-concentration oils, microencapsulated powders, emulsions and omega-3-rich algal biomass. DHA-rich oils commonly use Schizochytrium and related microorganisms and are predominantly triglyceride-based, while specialized phototrophic platforms such as Nannochloropsis provide an alternative route for EPA-rich ingredients. Product specifications are primarily defined by DHA/EPA concentration, lipid form, oxidation stability, sensory quality, contaminant limits and application-specific regulatory compliance. Algae Based Omega-3 is used across dietary supplements, infant and maternal nutrition, functional foods and beverages, medical or specialized nutrition, aquaculture feed, pet nutrition and other applications requiring a direct, non-fish source of long-chain omega-3 fatty acids. FDA GRAS documentation confirms commercial Schizochytrium-derived algal oils produced through fermentation, recovery and refining for food applications.
Key Findings
DHA-rich algal oil remains the most commercially mature product platform across food supplement and early-life nutrition applications
EPA and combined EPA+DHA products are broadening the market beyond traditional DHA-dominant formulations
Controlled fermentation underpins many leading commercial DHA and EPA+DHA production platforms
Oil and microencapsulated powder are major human-nutrition formats while omega-3-rich biomass has greater relevance in animal nutrition
In 2025, global algae based Omega-3 average price is 65 usd/kg
Market Trends
The Algae Based Omega-3 industry is progressing from conventional DHA-focused algal oil toward broader EPA, EPA+DHA, higher-potency and formulation-ready product platforms. The most important technical shift is occurring at the strain and fermentation level: producers are improving lipid productivity and fatty-acid profiles so that higher omega-3 concentrations can be achieved biologically before downstream concentration. Fermentalg’s 2026 launch of an algal oil containing 40% EPA and 20% DHA without a separate concentration step illustrates this direction. Product innovation is simultaneously moving downstream into microencapsulation, emulsification and sensory optimization, enabling higher omega-3 loading in gummies, soft chews, functional beverages and other formats that historically presented oxidation, taste and stability challenges. dsm-firmenich’s 2026 high-potency microencapsulated omega-3 powder and Corbion’s continuing development of DHA-rich algal biomass suspension technology demonstrate that competitive differentiation increasingly depends not only on EPA/DHA content but also on delivery format, oxidative protection, processability and application performance. The longer-term industry direction is therefore toward vertically integrated biological production combined with increasingly sophisticated ingredient formulation rather than simple replacement of fish oil on a kilogram-for-kilogram basis.
Market Dynamics
Drivers
Demand for Algae Based Omega-3 is supported by the need for additional scalable sources of long-chain EPA and DHA beyond conventional marine fisheries, combined with continued demand from nutritional supplements, early-life nutrition, aquaculture and pet nutrition. Microalgae occupy the base of the marine food chain and directly synthesize long-chain omega-3 fatty acids, allowing industrial producers to bypass fish as an intermediate source. Controlled fermentation provides comparatively predictable production conditions and reduces exposure to fluctuations in wild-fish availability, while also supporting vegetarian and vegan product positioning. In aquaculture, the issue is particularly structural because growth in farmed seafood requires reliable EPA and DHA inputs while the supply of conventional marine omega-3 cannot expand indefinitely. Corbion has commercialized industrial-scale fermented DHA ingredients as an alternative to fish oil, while Veramaris operates a dedicated fermentation facility producing EPA+DHA algal oil for fish and shrimp nutrition. Human nutrition provides an additional demand pillar through supplements, infant nutrition and new delivery formats, supporting a diversified end-market structure rather than dependence on one application.
Restraints
The principal restraint is production economics. Industrial Algae Based Omega-3 requires high-performing strains, sterile fermentation or controlled cultivation, carbohydrate or nutrient feedstocks, aeration, energy, biomass separation, oil recovery, refining and stabilization, creating a cost structure that is materially more complex than commodity edible oils. High-concentration products add molecular separation, winterization, deodorization or other purification operations, further increasing processing costs. Phototrophic EPA routes face a different cost profile associated with cultivation area, harvesting and relatively dilute biomass. Oxidative sensitivity also raises packaging, antioxidant and inventory-management requirements. Regulatory approvals are another constraint because commercial acceptance can depend on specific microorganism strains, manufacturing processes, composition and intended applications rather than simply the generic description “algal oil”; infant formula and other sensitive nutrition applications require particularly rigorous qualification. As a result, new entrants face a combination of biological scale-up risk, capital requirements, food-quality compliance and lengthy customer validation, while established producers must continuously improve yields to narrow the cost gap with conventional marine omega-3 sources.
Opportunities
The most significant opportunity lies in expanding the market from DHA-centric products into broader EPA and balanced EPA+DHA nutrition. High-EPA microalgal strains and advanced concentration technologies are enabling products that more closely replicate or exceed the fatty-acid profiles traditionally associated with concentrated fish oils. Fermentalg’s new naturally concentrated EPA+DHA platform and KD Nutra’s Alga3 technology, which can produce highly concentrated algal EPA or DHA ingredients, illustrate two distinct routes—biological optimization and downstream concentration—to higher-value products. A second opportunity is formulation technology. Microencapsulation and emulsification allow Algae Based Omega-3 to enter gummies, powders, beverages, dairy alternatives and other formats where conventional oils face sensory and stability limitations. Aquaculture and pet nutrition represent another sizeable pathway because algae can deliver EPA/DHA directly into animal diets rather than relying on forage-fish oil. In human nutrition, aging, cardiovascular, cognition, maternal and early-life applications provide opportunities for differentiated dosage and composition platforms. This combination supports an industry shift from a relatively narrow DHA ingredient category toward a broader portfolio of functional lipids tailored by fatty-acid ratio, concentration, delivery form and end-use requirement.
Challenges
Scaling biological productivity while maintaining consistent fatty-acid composition is the central manufacturing challenge. Strain performance, fermentation conditions, carbon-source efficiency, oxygen transfer, biomass density and lipid recovery directly affect production economics, while small variations can influence DHA/EPA yield and sensory quality. Downstream operations must simultaneously control oxidation, odor, color, saturated-fat fractions and other impurities without materially degrading sensitive long-chain polyunsaturated fatty acids. High-concentration products face even tighter requirements for thermal exposure and oxidative stability. The regulatory environment adds another layer of complexity because different jurisdictions evaluate specific strains and intended food uses, requiring manufacturers to maintain traceability from strain bank through finished oil. Intellectual-property competition also remains relevant as companies develop proprietary strains, fermentation methods and high-potency lipid profiles; recent European patent proceedings between Mara Renewables and dsm-firmenich demonstrate that freedom to operate around high-DHA microalgal technology can have strategic significance. Finally, customers increasingly expect manufacturers to demonstrate not only nutrition and purity but also reliable supply, life-cycle sustainability and price competitiveness, raising the threshold for successful commercialization.
Industry Chain Analysis
The upstream chain of Algae Based Omega-3 begins with proprietary microalgal strains, strain banks, fermentation or cultivation media, carbohydrate feedstocks, nitrogen sources, minerals, oxygen, process water and specialized biological-production equipment. Heterotrophic processes rely heavily on fermentation infrastructure, sterile processing and feedstock economics, whereas phototrophic production requires suitable light, carbon dioxide, cultivation systems and efficient harvesting. Other upstream inputs include antioxidants, carrier oils, encapsulation materials, high-barrier packaging and analytical reagents. The strategic importance of the strain is unusually high because growth rate, lipid accumulation and EPA/DHA profile ultimately determine fermentation productivity and downstream processing requirements.
The midstream stage covers cultivation or fermentation, biomass harvesting, dewatering, cell disruption, oil recovery, crude-oil refining, deodorization, winterization, purification, concentration, antioxidant stabilization and formulation into oils, powders or emulsions. Value creation is concentrated in strain productivity, fermentation yield, recovery efficiency, oxidation management, high-purity separation and regulatory-quality systems. Companies that purchase crude algal oil and specialize in concentration occupy a distinct part of the chain from companies that generate the original algal biomass, making double counting an important issue in market-size and company-share analysis. Downstream customers include supplement manufacturers, infant-formula producers, food and beverage companies, medical-nutrition companies, aquafeed manufacturers and pet-food producers. Higher-margin value increasingly shifts toward customized EPA:DHA ratios, high-concentration oils, microencapsulated systems, application support and regulatory documentation rather than undifferentiated crude oil alone.
Segment Insights
DHA-dominant Algae Based Omega-3 remains the most mature commercial segment. Schizochytrium-derived DHA oil has a long regulatory and commercial history in conventional foods and infant nutrition, and standard commercial oil grades commonly fall around the mid-30% to 50% DHA range. FDA records contain multiple GRAS notifications for Schizochytrium-derived oils at approximately 35% DHA and above, while current Chinese producers such as Runke commercially offer 35%, 40% and 50% DHA oil grades. This established product architecture benefits from mature fermentation technology, recognized applications and extensive downstream formulation experience.
The higher-growth technology opportunity is shifting toward EPA-rich, EPA+DHA and high-concentration products. Fermentalg’s 2026 platform reaches up to 60% total EPA+DHA directly through fermentation, while specialized processors can raise algae-derived EPA or DHA concentrations substantially further through downstream purification. Phototrophic Nannochloropsis platforms provide another differentiated EPA route, represented in the confirmed producer pool by companies such as Qualitas Health, AlgaeCytes and Xiaozao Technology. Product form creates an additional segmentation layer: refined oils dominate concentrated nutritional applications, microencapsulated powders expand compatibility with dry and chewable formats, and DHA-rich whole-algae biomass has a stronger position in aquaculture, pet food and animal nutrition. This diversification increases the importance of evaluating the market by active EPA/DHA content and value-added processing rather than by total ingredient tonnage alone.
Downstream Market Opportunities
Human dietary supplements remain a core opportunity for Algae Based Omega-3, particularly where consumers and brands seek vegetarian or fish-free EPA/DHA sources, but the addressable market is broadening rapidly. Early-life and maternal nutrition remain highly relevant for DHA-rich ingredients, supported by established regulatory use of Schizochytrium oils, while microencapsulation is opening higher-load applications in gummies, soft chews, powders and functional foods. Functional beverages, dairy and dairy alternatives offer additional formulation opportunities when emulsification and oxidation control can maintain sensory quality. Aquaculture is strategically important because algae-derived EPA and DHA can substitute part of the marine-oil requirement in salmon, shrimp and other species, helping decouple farmed seafood growth from forage-fish availability. Pet food is another expanding application, with DHA-rich biomass and oils increasingly incorporated into premium nutrition. The commercial opportunity therefore spans different price points and specifications, from large-volume feed ingredients to highly purified human-nutrition concentrates, with application engineering and formulation technology determining how much additional value can be captured from the same underlying algal lipid.
Regional Insights
North America and Europe are important high-value markets and technology centers for Algae Based Omega-3, with established demand from supplements, functional nutrition, aquaculture and pet nutrition as well as a concentration of high-purity and advanced-fermentation technologies. North America hosts significant commercial production infrastructure, including the Veramaris facility in Nebraska, while Mara combines Canadian R&D with commercial algal Omega-3 manufacturing in the United Kingdom. European producers and processors have expanded the market toward naturally concentrated EPA+DHA, specialty ratios and high-purity concentrates, supported by established novel-food and ingredient approval frameworks.
Asia, particularly China, has developed into an important production base for DHA algal oil and an emerging base for microalgal EPA. The confirmed Chinese producer pool spans established fermentation suppliers such as CABIO and Runke, additional DHA manufacturers across several provinces, high-concentration processors, and newer EPA-oriented platforms such as Xiaozao Technology. CABIO reported continued growth in algal DHA demand from infant-nutrition customers in 2025 and ongoing expansion of fermentation and refining capabilities, while Runke operates an integrated microalgae platform covering strain development, ingredient production and downstream nutrition products. China’s manufacturing position is therefore increasingly differentiated: mature DHA fermentation supports domestic infant and food applications, while EPA, high-concentration oils and international customer qualification provide the next layer of regional opportunity.
Competitive Landscape Analysis
The competitive landscape of Algae Based Omega-3 is defined by differences in biological platform, vertical integration and downstream processing depth rather than by a single standardized production model. dsm-firmenich, Corbion, Veramaris, Fermentalg and Mara Renewables operate differentiated fermentation-based platforms, with competition increasingly centered on strain productivity, natural EPA/DHA concentration, scale, supply security and application breadth. Qualitas Health, AlgaeCytes and Xiaozao Technology represent the more specialized phototrophic EPA route, while KD Pharma Group, Solutex, Polaris and GC Rieber VivoMega add value primarily through refining, molecular separation and high-concentration omega-3 processing. ADM and Alltech participate through broader nutrition and fermentation capabilities, while Cellana represents a whole-algae and phototrophic platform. China has developed a substantial manufacturing cluster led by confirmed producers including CABIO, Runke, Hubei Fuxing Biotechnology, Xiamen Huison, Qingdao Keyuan Marine Biochemistry, Hubei Xinhe Biotechnology, Zhejiang Grand Biotech, Shandong Tianzhi Green Industry, Xiaozao Technology, Inner Mongolia Kingdomway Pharmaceutical, Zhihe Biotechnology and Zhejiang EastBio. Competitive advantage is increasingly determined by the ability to combine low-cost biological productivity with clean sensory performance, oxidation stability, regulatory qualification, customized EPA:DHA ratios and customer-specific delivery formats.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Algae Based Omega-3 market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Materials and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (capacity, sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Dsm-firmenich
Solutex
KD Pharma Group
Polaris
Corbion
Veramaris
Fermentalg
Mara Renewables Corporation
Qualitas Health
AlgaeCytes
ADM
Alltech
Cellana
GC Rieber VivoMega
CABIO Biotech (Wuhan) Co., Ltd.
Guangdong Runke Bioengineering Co., Ltd.
Hubei Fuxing Biotechnology Co., Ltd.
Xiamen Huison Biotech Co., Ltd.
Qingdao Keyuan Marine Biochemistry Co., Ltd.
Hubei Xinhe Biotechnology Co., Ltd.
Zhejiang Grand Biotech Co., Ltd.
Shandong Tianzhi Green Industry Biotechnology Co., Ltd.
Xiaozao Technology (Anji) Co., Ltd.
Inner Mongolia Kingdomway Pharmaceutical Co., Ltd.
Zhihe Biotechnology (Changzhou) Co., Ltd.
Zhejiang EastBio Biotechnology Co., Ltd.
Segment by Materials
DHA-Dominant Algae Based Omega-3
EPA-Dominant Algae Based Omega-3
EPA+DHA Algae Based Omega-3
Segment by State
Algal Omega-3 Oil
Microencapsulated Algal Omega-3 Powder
Omega-3-Rich Algal Biomass
Algal Omega-3 Emulsion
Segment by Concentration
Standard-Concentration Algae Based Omega-3
High-Concentration Algae Based Omega-3
Segment by Application
Dietary Supplements
Infant Formula
Maternal Nutrition
Functional Foods and Beverages
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Algae Based Omega-3 study scope, segments the market by Materials and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue, sales, and production to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: Maps global production capacity, utilization, and market share (2021–2032), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks
Chapter 7: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 8: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 9: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 10: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 11: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth: details product specs, capacity, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 13: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles
Chapter 14: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 7-11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Algae Based Omega-3: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Materials
1.2.1 Global Algae Based Omega-3 Market Size by Materials, 2021 vs 2025 vs 2032
1.2.2 DHA-Dominant Algae Based Omega-3
1.2.3 EPA-Dominant Algae Based Omega-3
1.2.4 EPA+DHA Algae Based Omega-3
1.3 Market Segmentation by State
1.3.1 Global Algae Based Omega-3 Market Size by State, 2021 vs 2025 vs 2032
1.3.2 Algal Omega-3 Oil
1.3.3 Microencapsulated Algal Omega-3 Powder
1.3.4 Omega-3-Rich Algal Biomass
1.3.5 Algal Omega-3 Emulsion
1.4 Market Segmentation by Concentration
1.4.1 Global Algae Based Omega-3 Market Size by Concentration, 2021 vs 2025 vs 2032
1.4.2 Standard-Concentration Algae Based Omega-3
1.4.3 High-Concentration Algae Based Omega-3
1.5 Market Segmentation by Application
1.5.1 Global Algae Based Omega-3 Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Dietary Supplements
1.5.3 Infant Formula
1.5.4 Maternal Nutrition
1.5.5 Functional Foods and Beverages
1.5.6 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Algae Based Omega-3 Revenue Estimates and Forecasts (2021-2032)
2.2 Global Algae Based Omega-3 Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Algae Based Omega-3 Sales Estimates and Forecasts (2021-2032)
2.4 Global Algae Based Omega-3 Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Global Sales Market Share by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.5 Global Algae Based Omega-3 Production Capacity and Utilization (2021 vs 2025 vs 2032)
2.6 Production Comparison by Region: 2021 vs 2025 vs 2032

3 Competitive Landscape
3.1 Global Algae Based Omega-3 Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Algae Based Omega-3 Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs. 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 DHA-Dominant Algae Based Omega-3: Market Share by Key Manufacturers
3.5.2 EPA-Dominant Algae Based Omega-3: Market Share by Key Manufacturers
3.5.3 EPA+DHA Algae Based Omega-3: Market Share by Key Manufacturers
3.6 Global Algae Based Omega-3 Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Market Entry and Exit Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Algae Based Omega-3 Sales Performance by Materials
4.1.1 Global Algae Based Omega-3 Sales Volume by Materials (2021-2032)
4.1.2 Global Algae Based Omega-3 Revenue by Materials (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Materials (2021-2032)
4.2 Global Algae Based Omega-3 Sales Performance by State
4.2.1 Global Algae Based Omega-3 Sales Volume by State (2021-2032)
4.2.2 Global Algae Based Omega-3 Revenue by State (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by State (2021-2032)
4.3 Global Algae Based Omega-3 Sales Performance by Concentration
4.3.1 Global Algae Based Omega-3 Sales Volume by Concentration (2021-2032)
4.3.2 Global Algae Based Omega-3 Revenue by Concentration (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Concentration (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Algae Based Omega-3 Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Algae Based Omega-3 Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 Global Production Analysis
6.1 Global Algae Based Omega-3 Production Capacity and Utilization Rates (2021–2032)
6.2 Regional Production Dynamics and Outlook
6.2.1 Historic Production by Region (2021-2026)
6.2.2 Forecasted Production by Region (2027-2032)
6.2.3 Production Market Share by Region (2021-2032)
6.2.4 Regulatory and Trade Policy Impact on Production
6.2.5 Production Capacity Enablers and Constraints
6.3 Key Regional Production Hubs
6.3.1 North America
6.3.2 Europe
6.3.3 China

7 North America
7.1 North America Sales Volume and Revenue (2021-2032)
7.2 North America Key Manufacturers Sales Revenue in 2025
7.3 North America Algae Based Omega-3 Sales and Revenue by Application (2021-2032)
7.4 North America Growth Accelerators and Market Barriers
7.5 North America Algae Based Omega-3 Market Size by Country
7.5.1 North America Revenue by Country
7.5.2 North America Sales Trends by Country
7.5.3 US
7.5.4 Canada
7.5.5 Mexico

8 Europe
8.1 Europe Sales Volume and Revenue (2021-2032)
8.2 Europe Key Manufacturers Sales Revenue in 2025
8.3 Europe Algae Based Omega-3 Sales and Revenue by Application (2021-2032)
8.4 Europe Growth Accelerators and Market Barriers
8.5 Europe Algae Based Omega-3 Market Size by Country
8.5.1 Europe Revenue by Country
8.5.2 Europe Sales Trends by Country
8.5.3 Germany
8.5.4 France
8.5.5 U.K.
8.5.6 Italy
8.5.7 Russia

9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
9.3 Asia-Pacific Algae Based Omega-3 Sales and Revenue by Application (2021-2032)
9.4 Asia-Pacific Algae Based Omega-3 Market Size by Region
9.4.1 Asia-Pacific Revenue by Region
9.4.2 Asia-Pacific Sales Trends by Region
9.5 Asia-Pacific Growth Accelerators and Market Barriers
9.6 Southeast Asia
9.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
9.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.7 China
9.8 Japan
9.9 South Korea
9.10 China Taiwan
9.11 India

10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2021-2032)
10.2 Central and South America Key Manufacturers Sales Revenue in 2025
10.3 Central and South America Algae Based Omega-3 Sales and Revenue by Application (2021-2032)
10.4 Central and South America Investment Opportunities and Key Challenges
10.5 Central and South America Algae Based Omega-3 Market Size by Country
10.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 Brazil
10.5.3 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
11.3 Middle East and Africa Algae Based Omega-3 Sales and Revenue by Application (2021-2032)
11.4 Middle East and Africa Investment Opportunities and Key Challenges
11.5 Middle East and Africa Algae Based Omega-3 Market Size by Country
11.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
11.5.2 GCC Countries
11.5.3 Turkey
11.5.4 Egypt
11.5.5 South Africa

12 Corporate Profile
12.1 Dsm-firmenich
12.1.1 Dsm-firmenich Corporation Information
12.1.2 Dsm-firmenich Business Overview
12.1.3 Dsm-firmenich Algae Based Omega-3 Product Models, Descriptions and Specifications
12.1.4 Dsm-firmenich Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.1.5 Dsm-firmenich Algae Based Omega-3 Sales by Product in 2025
12.1.6 Dsm-firmenich Algae Based Omega-3 Sales by Application in 2025
12.1.7 Dsm-firmenich Algae Based Omega-3 Sales by Geographic Area in 2025
12.1.8 Dsm-firmenich Algae Based Omega-3 SWOT Analysis
12.1.9 Dsm-firmenich Recent Developments
12.2 Solutex
12.2.1 Solutex Corporation Information
12.2.2 Solutex Business Overview
12.2.3 Solutex Algae Based Omega-3 Product Models, Descriptions and Specifications
12.2.4 Solutex Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.2.5 Solutex Algae Based Omega-3 Sales by Product in 2025
12.2.6 Solutex Algae Based Omega-3 Sales by Application in 2025
12.2.7 Solutex Algae Based Omega-3 Sales by Geographic Area in 2025
12.2.8 Solutex Algae Based Omega-3 SWOT Analysis
12.2.9 Solutex Recent Developments
12.3 KD Pharma Group
12.3.1 KD Pharma Group Corporation Information
12.3.2 KD Pharma Group Business Overview
12.3.3 KD Pharma Group Algae Based Omega-3 Product Models, Descriptions and Specifications
12.3.4 KD Pharma Group Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.3.5 KD Pharma Group Algae Based Omega-3 Sales by Product in 2025
12.3.6 KD Pharma Group Algae Based Omega-3 Sales by Application in 2025
12.3.7 KD Pharma Group Algae Based Omega-3 Sales by Geographic Area in 2025
12.3.8 KD Pharma Group Algae Based Omega-3 SWOT Analysis
12.3.9 KD Pharma Group Recent Developments
12.4 Polaris
12.4.1 Polaris Corporation Information
12.4.2 Polaris Business Overview
12.4.3 Polaris Algae Based Omega-3 Product Models, Descriptions and Specifications
12.4.4 Polaris Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.4.5 Polaris Algae Based Omega-3 Sales by Product in 2025
12.4.6 Polaris Algae Based Omega-3 Sales by Application in 2025
12.4.7 Polaris Algae Based Omega-3 Sales by Geographic Area in 2025
12.4.8 Polaris Algae Based Omega-3 SWOT Analysis
12.4.9 Polaris Recent Developments
12.5 Corbion
12.5.1 Corbion Corporation Information
12.5.2 Corbion Business Overview
12.5.3 Corbion Algae Based Omega-3 Product Models, Descriptions and Specifications
12.5.4 Corbion Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.5.5 Corbion Algae Based Omega-3 Sales by Product in 2025
12.5.6 Corbion Algae Based Omega-3 Sales by Application in 2025
12.5.7 Corbion Algae Based Omega-3 Sales by Geographic Area in 2025
12.5.8 Corbion Algae Based Omega-3 SWOT Analysis
12.5.9 Corbion Recent Developments
12.6 Veramaris
12.6.1 Veramaris Corporation Information
12.6.2 Veramaris Business Overview
12.6.3 Veramaris Algae Based Omega-3 Product Models, Descriptions and Specifications
12.6.4 Veramaris Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.6.5 Veramaris Recent Developments
12.7 Fermentalg
12.7.1 Fermentalg Corporation Information
12.7.2 Fermentalg Business Overview
12.7.3 Fermentalg Algae Based Omega-3 Product Models, Descriptions and Specifications
12.7.4 Fermentalg Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.7.5 Fermentalg Recent Developments
12.8 Mara Renewables Corporation
12.8.1 Mara Renewables Corporation Corporation Information
12.8.2 Mara Renewables Corporation Business Overview
12.8.3 Mara Renewables Corporation Algae Based Omega-3 Product Models, Descriptions and Specifications
12.8.4 Mara Renewables Corporation Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.8.5 Mara Renewables Corporation Recent Developments
12.9 Qualitas Health
12.9.1 Qualitas Health Corporation Information
12.9.2 Qualitas Health Business Overview
12.9.3 Qualitas Health Algae Based Omega-3 Product Models, Descriptions and Specifications
12.9.4 Qualitas Health Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.9.5 Qualitas Health Recent Developments
12.10 AlgaeCytes
12.10.1 AlgaeCytes Corporation Information
12.10.2 AlgaeCytes Business Overview
12.10.3 AlgaeCytes Algae Based Omega-3 Product Models, Descriptions and Specifications
12.10.4 AlgaeCytes Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.10.5 AlgaeCytes Recent Developments
12.11 ADM
12.11.1 ADM Corporation Information
12.11.2 ADM Business Overview
12.11.3 ADM Algae Based Omega-3 Product Models, Descriptions and Specifications
12.11.4 ADM Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.11.5 ADM Recent Developments
12.12 Alltech
12.12.1 Alltech Corporation Information
12.12.2 Alltech Business Overview
12.12.3 Alltech Algae Based Omega-3 Product Models, Descriptions and Specifications
12.12.4 Alltech Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.12.5 Alltech Recent Developments
12.13 Cellana
12.13.1 Cellana Corporation Information
12.13.2 Cellana Business Overview
12.13.3 Cellana Algae Based Omega-3 Product Models, Descriptions and Specifications
12.13.4 Cellana Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.13.5 Cellana Recent Developments
12.14 GC Rieber VivoMega
12.14.1 GC Rieber VivoMega Corporation Information
12.14.2 GC Rieber VivoMega Business Overview
12.14.3 GC Rieber VivoMega Algae Based Omega-3 Product Models, Descriptions and Specifications
12.14.4 GC Rieber VivoMega Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.14.5 GC Rieber VivoMega Recent Developments
12.15 CABIO Biotech (Wuhan) Co., Ltd.
12.15.1 CABIO Biotech (Wuhan) Co., Ltd. Corporation Information
12.15.2 CABIO Biotech (Wuhan) Co., Ltd. Business Overview
12.15.3 CABIO Biotech (Wuhan) Co., Ltd. Algae Based Omega-3 Product Models, Descriptions and Specifications
12.15.4 CABIO Biotech (Wuhan) Co., Ltd. Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.15.5 CABIO Biotech (Wuhan) Co., Ltd. Recent Developments
12.16 Guangdong Runke Bioengineering Co., Ltd.
12.16.1 Guangdong Runke Bioengineering Co., Ltd. Corporation Information
12.16.2 Guangdong Runke Bioengineering Co., Ltd. Business Overview
12.16.3 Guangdong Runke Bioengineering Co., Ltd. Algae Based Omega-3 Product Models, Descriptions and Specifications
12.16.4 Guangdong Runke Bioengineering Co., Ltd. Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.16.5 Guangdong Runke Bioengineering Co., Ltd. Recent Developments
12.17 Hubei Fuxing Biotechnology Co., Ltd.
12.17.1 Hubei Fuxing Biotechnology Co., Ltd. Corporation Information
12.17.2 Hubei Fuxing Biotechnology Co., Ltd. Business Overview
12.17.3 Hubei Fuxing Biotechnology Co., Ltd. Algae Based Omega-3 Product Models, Descriptions and Specifications
12.17.4 Hubei Fuxing Biotechnology Co., Ltd. Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.17.5 Hubei Fuxing Biotechnology Co., Ltd. Recent Developments
12.18 Xiamen Huison Biotech Co., Ltd.
12.18.1 Xiamen Huison Biotech Co., Ltd. Corporation Information
12.18.2 Xiamen Huison Biotech Co., Ltd. Business Overview
12.18.3 Xiamen Huison Biotech Co., Ltd. Algae Based Omega-3 Product Models, Descriptions and Specifications
12.18.4 Xiamen Huison Biotech Co., Ltd. Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.18.5 Xiamen Huison Biotech Co., Ltd. Recent Developments
12.19 Qingdao Keyuan Marine Biochemistry Co., Ltd.
12.19.1 Qingdao Keyuan Marine Biochemistry Co., Ltd. Corporation Information
12.19.2 Qingdao Keyuan Marine Biochemistry Co., Ltd. Business Overview
12.19.3 Qingdao Keyuan Marine Biochemistry Co., Ltd. Algae Based Omega-3 Product Models, Descriptions and Specifications
12.19.4 Qingdao Keyuan Marine Biochemistry Co., Ltd. Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.19.5 Qingdao Keyuan Marine Biochemistry Co., Ltd. Recent Developments
12.20 Hubei Xinhe Biotechnology Co., Ltd.
12.20.1 Hubei Xinhe Biotechnology Co., Ltd. Corporation Information
12.20.2 Hubei Xinhe Biotechnology Co., Ltd. Business Overview
12.20.3 Hubei Xinhe Biotechnology Co., Ltd. Algae Based Omega-3 Product Models, Descriptions and Specifications
12.20.4 Hubei Xinhe Biotechnology Co., Ltd. Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.20.5 Hubei Xinhe Biotechnology Co., Ltd. Recent Developments
12.21 Zhejiang Grand Biotech Co., Ltd.
12.21.1 Zhejiang Grand Biotech Co., Ltd. Corporation Information
12.21.2 Zhejiang Grand Biotech Co., Ltd. Business Overview
12.21.3 Zhejiang Grand Biotech Co., Ltd. Algae Based Omega-3 Product Models, Descriptions and Specifications
12.21.4 Zhejiang Grand Biotech Co., Ltd. Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.21.5 Zhejiang Grand Biotech Co., Ltd. Recent Developments
12.22 Shandong Tianzhi Green Industry Biotechnology Co., Ltd.
12.22.1 Shandong Tianzhi Green Industry Biotechnology Co., Ltd. Corporation Information
12.22.2 Shandong Tianzhi Green Industry Biotechnology Co., Ltd. Business Overview
12.22.3 Shandong Tianzhi Green Industry Biotechnology Co., Ltd. Algae Based Omega-3 Product Models, Descriptions and Specifications
12.22.4 Shandong Tianzhi Green Industry Biotechnology Co., Ltd. Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.22.5 Shandong Tianzhi Green Industry Biotechnology Co., Ltd. Recent Developments
12.23 Xiaozao Technology (Anji) Co., Ltd.
12.23.1 Xiaozao Technology (Anji) Co., Ltd. Corporation Information
12.23.2 Xiaozao Technology (Anji) Co., Ltd. Business Overview
12.23.3 Xiaozao Technology (Anji) Co., Ltd. Algae Based Omega-3 Product Models, Descriptions and Specifications
12.23.4 Xiaozao Technology (Anji) Co., Ltd. Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.23.5 Xiaozao Technology (Anji) Co., Ltd. Recent Developments
12.24 Inner Mongolia Kingdomway Pharmaceutical Co., Ltd.
12.24.1 Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. Corporation Information
12.24.2 Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. Business Overview
12.24.3 Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. Algae Based Omega-3 Product Models, Descriptions and Specifications
12.24.4 Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.24.5 Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. Recent Developments
12.25 Zhihe Biotechnology (Changzhou) Co., Ltd.
12.25.1 Zhihe Biotechnology (Changzhou) Co., Ltd. Corporation Information
12.25.2 Zhihe Biotechnology (Changzhou) Co., Ltd. Business Overview
12.25.3 Zhihe Biotechnology (Changzhou) Co., Ltd. Algae Based Omega-3 Product Models, Descriptions and Specifications
12.25.4 Zhihe Biotechnology (Changzhou) Co., Ltd. Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.25.5 Zhihe Biotechnology (Changzhou) Co., Ltd. Recent Developments
12.26 Zhejiang EastBio Biotechnology Co., Ltd.
12.26.1 Zhejiang EastBio Biotechnology Co., Ltd. Corporation Information
12.26.2 Zhejiang EastBio Biotechnology Co., Ltd. Business Overview
12.26.3 Zhejiang EastBio Biotechnology Co., Ltd. Algae Based Omega-3 Product Models, Descriptions and Specifications
12.26.4 Zhejiang EastBio Biotechnology Co., Ltd. Algae Based Omega-3 Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.26.5 Zhejiang EastBio Biotechnology Co., Ltd. Recent Developments

13 Value Chain and Supply-Chain Analysis
13.1 Algae Based Omega-3 Industry Chain
13.2 Algae Based Omega-3 Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Algae Based Omega-3 Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Algae Based Omega-3 Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors

14 Algae Based Omega-3 Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
14.4 Impact of U.S. Tariffs

15 Key Findings in the Global Algae Based Omega-3 Study

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Algae Based Omega-3 Market Size Growth Rate by Materials, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Algae Based Omega-3 Market Size Growth Rate by State, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Algae Based Omega-3 Market Size Growth Rate by Concentration, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Algae Based Omega-3 Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Algae Based Omega-3 Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Algae Based Omega-3 Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (MT)
Table 7. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 8. Global Algae Based Omega-3 Production Growth Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (MT)
Table 9. Global Algae Based Omega-3 Sales by Manufacturers (MT), 2021-2026
Table 10. Global Algae Based Omega-3 Sales Share by Manufacturers (2021-2026)
Table 11. Global Algae Based Omega-3 Revenue by Manufacturers (US$ Million), 2021-2026
Table 12. Global Algae Based Omega-3 Revenue-Based Market Share by Manufacturers (2021-2026)
Table 13. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 14. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Algae Based Omega-3 Revenue, 2025
Table 15. Global Algae Based Omega-3 Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 16. Global Algae Based Omega-3 Average Selling Price (ASP) by Manufacturers (US$/kg), 2021-2026
Table 17. Key Manufacturers Algae Based Omega-3 Manufacturing Base and Headquarters
Table 18. Global Algae Based Omega-3 Market Concentration Ratio (CR5)
Table 19. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 20. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 21. Global Algae Based Omega-3 Sales Volume by Materials (MT), 2021-2026
Table 22. Global Algae Based Omega-3 Sales Volume by Materials (MT), 2027-2032
Table 23. Global Algae Based Omega-3 Revenue by Materials (US$ Million), 2021-2026
Table 24. Global Algae Based Omega-3 Revenue by Materials (US$ Million), 2027-2032
Table 25. Global Algae Based Omega-3 Sales Volume by State (MT), 2021-2026
Table 26. Global Algae Based Omega-3 Sales Volume by State (MT), 2027-2032
Table 27. Global Algae Based Omega-3 Revenue by State (US$ Million), 2021-2026
Table 28. Global Algae Based Omega-3 Revenue by State (US$ Million), 2027-2032
Table 29. Global Algae Based Omega-3 Sales Volume by Concentration (MT), 2021-2026
Table 30. Global Algae Based Omega-3 Sales Volume by Concentration (MT), 2027-2032
Table 31. Global Algae Based Omega-3 Revenue by Concentration (US$ Million), 2021-2026
Table 32. Global Algae Based Omega-3 Revenue by Concentration (US$ Million), 2027-2032
Table 33. Technical Specifications by Key Product Type
Table 34. Global Algae Based Omega-3 Sales by Application (MT), 2021-2026
Table 35. Global Algae Based Omega-3 Sales by Application (MT), 2027-2032
Table 36. Algae Based Omega-3 High-Growth Sectors Demand CAGR (2026-2032)
Table 37. Global Algae Based Omega-3 Revenue by Application (US$ Million), 2021-2026
Table 38. Global Algae Based Omega-3 Revenue by Application (US$ Million), 2027-2032
Table 39. Top Customers by Region
Table 40. Top Customers by Application
Table 41. Global Algae Based Omega-3 Production by Region (MT), 2021-2026
Table 42. Global Algae Based Omega-3 Production by Region (MT), 2027-2032
Table 43. North America Algae Based Omega-3 Growth Accelerators and Market Barriers
Table 44. North America Algae Based Omega-3 Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 45. North America Algae Based Omega-3 Sales (MT) by Country (2021 vs 2025 vs 2032)
Table 46. Europe Algae Based Omega-3 Growth Accelerators and Market Barriers
Table 47. Europe Algae Based Omega-3 Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Europe Algae Based Omega-3 Sales (MT) by Country (2021 vs 2025 vs 2032)
Table 49. Asia-Pacific Algae Based Omega-3 Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 50. Asia-Pacific Algae Based Omega-3 Sales (MT) by Country (2021 vs 2025 vs 2032)
Table 51. Asia-Pacific Algae Based Omega-3 Growth Accelerators and Market Barriers
Table 52. Southeast Asia Algae Based Omega-3 Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 53. Central and South America Algae Based Omega-3 Investment Opportunities and Key Challenges
Table 54. Central and South America Algae Based Omega-3 Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 55. Middle East and Africa Algae Based Omega-3 Investment Opportunities and Key Challenges
Table 56. Middle East and Africa Algae Based Omega-3 Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 57. Dsm-firmenich Corporation Information
Table 58. Dsm-firmenich Description and Major Businesses
Table 59. Dsm-firmenich Product Models, Descriptions and Specifications
Table 60. Dsm-firmenich Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 61. Dsm-firmenich Sales Value Proportion by Product in 2025
Table 62. Dsm-firmenich Sales Value Proportion by Application in 2025
Table 63. Dsm-firmenich Sales Value Proportion by Geographic Area in 2025
Table 64. Dsm-firmenich Algae Based Omega-3 SWOT Analysis
Table 65. Dsm-firmenich Recent Developments
Table 66. Solutex Corporation Information
Table 67. Solutex Description and Major Businesses
Table 68. Solutex Product Models, Descriptions and Specifications
Table 69. Solutex Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 70. Solutex Sales Value Proportion by Product in 2025
Table 71. Solutex Sales Value Proportion by Application in 2025
Table 72. Solutex Sales Value Proportion by Geographic Area in 2025
Table 73. Solutex Algae Based Omega-3 SWOT Analysis
Table 74. Solutex Recent Developments
Table 75. KD Pharma Group Corporation Information
Table 76. KD Pharma Group Description and Major Businesses
Table 77. KD Pharma Group Product Models, Descriptions and Specifications
Table 78. KD Pharma Group Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 79. KD Pharma Group Sales Value Proportion by Product in 2025
Table 80. KD Pharma Group Sales Value Proportion by Application in 2025
Table 81. KD Pharma Group Sales Value Proportion by Geographic Area in 2025
Table 82. KD Pharma Group Algae Based Omega-3 SWOT Analysis
Table 83. KD Pharma Group Recent Developments
Table 84. Polaris Corporation Information
Table 85. Polaris Description and Major Businesses
Table 86. Polaris Product Models, Descriptions and Specifications
Table 87. Polaris Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 88. Polaris Sales Value Proportion by Product in 2025
Table 89. Polaris Sales Value Proportion by Application in 2025
Table 90. Polaris Sales Value Proportion by Geographic Area in 2025
Table 91. Polaris Algae Based Omega-3 SWOT Analysis
Table 92. Polaris Recent Developments
Table 93. Corbion Corporation Information
Table 94. Corbion Description and Major Businesses
Table 95. Corbion Product Models, Descriptions and Specifications
Table 96. Corbion Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 97. Corbion Sales Value Proportion by Product in 2025
Table 98. Corbion Sales Value Proportion by Application in 2025
Table 99. Corbion Sales Value Proportion by Geographic Area in 2025
Table 100. Corbion Algae Based Omega-3 SWOT Analysis
Table 101. Corbion Recent Developments
Table 102. Veramaris Corporation Information
Table 103. Veramaris Description and Major Businesses
Table 104. Veramaris Product Models, Descriptions and Specifications
Table 105. Veramaris Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 106. Veramaris Recent Developments
Table 107. Fermentalg Corporation Information
Table 108. Fermentalg Description and Major Businesses
Table 109. Fermentalg Product Models, Descriptions and Specifications
Table 110. Fermentalg Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 111. Fermentalg Recent Developments
Table 112. Mara Renewables Corporation Corporation Information
Table 113. Mara Renewables Corporation Description and Major Businesses
Table 114. Mara Renewables Corporation Product Models, Descriptions and Specifications
Table 115. Mara Renewables Corporation Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 116. Mara Renewables Corporation Recent Developments
Table 117. Qualitas Health Corporation Information
Table 118. Qualitas Health Description and Major Businesses
Table 119. Qualitas Health Product Models, Descriptions and Specifications
Table 120. Qualitas Health Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 121. Qualitas Health Recent Developments
Table 122. AlgaeCytes Corporation Information
Table 123. AlgaeCytes Description and Major Businesses
Table 124. AlgaeCytes Product Models, Descriptions and Specifications
Table 125. AlgaeCytes Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 126. AlgaeCytes Recent Developments
Table 127. ADM Corporation Information
Table 128. ADM Description and Major Businesses
Table 129. ADM Product Models, Descriptions and Specifications
Table 130. ADM Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 131. ADM Recent Developments
Table 132. Alltech Corporation Information
Table 133. Alltech Description and Major Businesses
Table 134. Alltech Product Models, Descriptions and Specifications
Table 135. Alltech Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 136. Alltech Recent Developments
Table 137. Cellana Corporation Information
Table 138. Cellana Description and Major Businesses
Table 139. Cellana Product Models, Descriptions and Specifications
Table 140. Cellana Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 141. Cellana Recent Developments
Table 142. GC Rieber VivoMega Corporation Information
Table 143. GC Rieber VivoMega Description and Major Businesses
Table 144. GC Rieber VivoMega Product Models, Descriptions and Specifications
Table 145. GC Rieber VivoMega Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 146. GC Rieber VivoMega Recent Developments
Table 147. CABIO Biotech (Wuhan) Co., Ltd. Corporation Information
Table 148. CABIO Biotech (Wuhan) Co., Ltd. Description and Major Businesses
Table 149. CABIO Biotech (Wuhan) Co., Ltd. Product Models, Descriptions and Specifications
Table 150. CABIO Biotech (Wuhan) Co., Ltd. Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 151. CABIO Biotech (Wuhan) Co., Ltd. Recent Developments
Table 152. Guangdong Runke Bioengineering Co., Ltd. Corporation Information
Table 153. Guangdong Runke Bioengineering Co., Ltd. Description and Major Businesses
Table 154. Guangdong Runke Bioengineering Co., Ltd. Product Models, Descriptions and Specifications
Table 155. Guangdong Runke Bioengineering Co., Ltd. Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 156. Guangdong Runke Bioengineering Co., Ltd. Recent Developments
Table 157. Hubei Fuxing Biotechnology Co., Ltd. Corporation Information
Table 158. Hubei Fuxing Biotechnology Co., Ltd. Description and Major Businesses
Table 159. Hubei Fuxing Biotechnology Co., Ltd. Product Models, Descriptions and Specifications
Table 160. Hubei Fuxing Biotechnology Co., Ltd. Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 161. Hubei Fuxing Biotechnology Co., Ltd. Recent Developments
Table 162. Xiamen Huison Biotech Co., Ltd. Corporation Information
Table 163. Xiamen Huison Biotech Co., Ltd. Description and Major Businesses
Table 164. Xiamen Huison Biotech Co., Ltd. Product Models, Descriptions and Specifications
Table 165. Xiamen Huison Biotech Co., Ltd. Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 166. Xiamen Huison Biotech Co., Ltd. Recent Developments
Table 167. Qingdao Keyuan Marine Biochemistry Co., Ltd. Corporation Information
Table 168. Qingdao Keyuan Marine Biochemistry Co., Ltd. Description and Major Businesses
Table 169. Qingdao Keyuan Marine Biochemistry Co., Ltd. Product Models, Descriptions and Specifications
Table 170. Qingdao Keyuan Marine Biochemistry Co., Ltd. Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 171. Qingdao Keyuan Marine Biochemistry Co., Ltd. Recent Developments
Table 172. Hubei Xinhe Biotechnology Co., Ltd. Corporation Information
Table 173. Hubei Xinhe Biotechnology Co., Ltd. Description and Major Businesses
Table 174. Hubei Xinhe Biotechnology Co., Ltd. Product Models, Descriptions and Specifications
Table 175. Hubei Xinhe Biotechnology Co., Ltd. Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 176. Hubei Xinhe Biotechnology Co., Ltd. Recent Developments
Table 177. Zhejiang Grand Biotech Co., Ltd. Corporation Information
Table 178. Zhejiang Grand Biotech Co., Ltd. Description and Major Businesses
Table 179. Zhejiang Grand Biotech Co., Ltd. Product Models, Descriptions and Specifications
Table 180. Zhejiang Grand Biotech Co., Ltd. Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 181. Zhejiang Grand Biotech Co., Ltd. Recent Developments
Table 182. Shandong Tianzhi Green Industry Biotechnology Co., Ltd. Corporation Information
Table 183. Shandong Tianzhi Green Industry Biotechnology Co., Ltd. Description and Major Businesses
Table 184. Shandong Tianzhi Green Industry Biotechnology Co., Ltd. Product Models, Descriptions and Specifications
Table 185. Shandong Tianzhi Green Industry Biotechnology Co., Ltd. Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 186. Shandong Tianzhi Green Industry Biotechnology Co., Ltd. Recent Developments
Table 187. Xiaozao Technology (Anji) Co., Ltd. Corporation Information
Table 188. Xiaozao Technology (Anji) Co., Ltd. Description and Major Businesses
Table 189. Xiaozao Technology (Anji) Co., Ltd. Product Models, Descriptions and Specifications
Table 190. Xiaozao Technology (Anji) Co., Ltd. Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 191. Xiaozao Technology (Anji) Co., Ltd. Recent Developments
Table 192. Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. Corporation Information
Table 193. Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. Description and Major Businesses
Table 194. Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 195. Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 196. Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. Recent Developments
Table 197. Zhihe Biotechnology (Changzhou) Co., Ltd. Corporation Information
Table 198. Zhihe Biotechnology (Changzhou) Co., Ltd. Description and Major Businesses
Table 199. Zhihe Biotechnology (Changzhou) Co., Ltd. Product Models, Descriptions and Specifications
Table 200. Zhihe Biotechnology (Changzhou) Co., Ltd. Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 201. Zhihe Biotechnology (Changzhou) Co., Ltd. Recent Developments
Table 202. Zhejiang EastBio Biotechnology Co., Ltd. Corporation Information
Table 203. Zhejiang EastBio Biotechnology Co., Ltd. Description and Major Businesses
Table 204. Zhejiang EastBio Biotechnology Co., Ltd. Product Models, Descriptions and Specifications
Table 205. Zhejiang EastBio Biotechnology Co., Ltd. Capacity, Sales (MT), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 206. Zhejiang EastBio Biotechnology Co., Ltd. Recent Developments
Table 207. Key Raw Materials Distribution
Table 208. Raw Materials Key Suppliers
Table 209. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 210. Milestones in Production Technology Evolution
Table 211. Distributors List
Table 212. Market Trends and Market Evolution
Table 213. Market Drivers and Opportunities
Table 214. Market Challenges, Risks, and Restraints
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources

List of Figures
Figure 1. Algae Based Omega-3 Product Picture
Figure 2. Global Algae Based Omega-3 Market Size Growth Rate by Materials, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. DHA-Dominant Algae Based Omega-3 Product Picture
Figure 4. EPA-Dominant Algae Based Omega-3 Product Picture
Figure 5. EPA+DHA Algae Based Omega-3 Product Picture
Figure 6. Global Algae Based Omega-3 Market Size Growth Rate by State, 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. Algal Omega-3 Oil Product Picture
Figure 8. Microencapsulated Algal Omega-3 Powder Product Picture
Figure 9. Omega-3-Rich Algal Biomass Product Picture
Figure 10. Algal Omega-3 Emulsion Product Picture
Figure 11. Global Algae Based Omega-3 Market Size Growth Rate by Concentration, 2021 vs 2025 vs 2032 (US$ Million)
Figure 12. Standard-Concentration Algae Based Omega-3 Product Picture
Figure 13. High-Concentration Algae Based Omega-3 Product Picture
Figure 14. Global Algae Based Omega-3 Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Dietary Supplements
Figure 16. Infant Formula
Figure 17. Maternal Nutrition
Figure 18. Functional Foods and Beverages
Figure 19. Others
Figure 20. Algae Based Omega-3 Report Years Considered
Figure 21. Global Algae Based Omega-3 Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 23. Global Algae Based Omega-3 Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 24. Global Algae Based Omega-3 Revenue-Based Market Share by Region (2021-2032)
Figure 25. Global Algae Based Omega-3 Sales (MT), 2021-2032
Figure 26. Global Algae Based Omega-3 Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (MT)
Figure 27. Global Algae Based Omega-3 Sales Market Share by Region (2021-2032)
Figure 28. Global Algae Based Omega-3 Capacity, Production and Utilization (MT), 2021 vs 2025 vs 2032
Figure 29. Top 5 and Top 10 Manufacturers Algae Based Omega-3 Sales Volume Market Share in 2025
Figure 30. Global Algae Based Omega-3 Revenue-Based Market Share Ranking (2025)
Figure 31. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 32. DHA-Dominant Algae Based Omega-3 Revenue-Based Market Share by Manufacturer in 2025
Figure 33. EPA-Dominant Algae Based Omega-3 Revenue-Based Market Share by Manufacturer in 2025
Figure 34. EPA+DHA Algae Based Omega-3 Revenue-Based Market Share by Manufacturer in 2025
Figure 35. Global Algae Based Omega-3 Sales Volume-Based Market Share by Materials (2021-2032)
Figure 36. Global Algae Based Omega-3 Revenue-Based Market Share by Materials (2021-2032)
Figure 37. Global Algae Based Omega-3 ASP by Materials (US$/kg), 2021-2032
Figure 38. Global Algae Based Omega-3 Sales Volume-Based Market Share by State (2021-2032)
Figure 39. Global Algae Based Omega-3 Revenue-Based Market Share by State (2021-2032)
Figure 40. Global Algae Based Omega-3 ASP by State (US$/kg), 2021-2032
Figure 41. Global Algae Based Omega-3 Sales Volume-Based Market Share by Concentration (2021-2032)
Figure 42. Global Algae Based Omega-3 Revenue-Based Market Share by Concentration (2021-2032)
Figure 43. Global Algae Based Omega-3 ASP by Concentration (US$/kg), 2021-2032
Figure 44. Global Algae Based Omega-3 Sales Market Share by Application (2021-2032)
Figure 45. Global Algae Based Omega-3 Revenue-Based Market Share by Application (2021-2032)
Figure 46. Global Algae Based Omega-3 ASP by Application (US$/kg), 2021-2032
Figure 47. Global Algae Based Omega-3 Capacity, Production and Utilization (MT), 2021-2032
Figure 48. Global Algae Based Omega-3 Production Market Share by Region (2021-2032)
Figure 49. Production Capacity Enablers & Constraints
Figure 50. Algae Based Omega-3 Production Growth Rate in North America (MT), 2021-2032
Figure 51. Algae Based Omega-3 Production Growth Rate in Europe (MT), 2021-2032
Figure 52. Algae Based Omega-3 Production Growth Rate in China (MT), 2021-2032
Figure 53. North America Algae Based Omega-3 Sales YoY (MT), 2021-2032
Figure 54. North America Algae Based Omega-3 Revenue YoY (US$ Million), 2021-2032
Figure 55. North America Top 5 Manufacturers Algae Based Omega-3 Sales Revenue (US$ Million) in 2025
Figure 56. North America Algae Based Omega-3 Sales Volume (MT) by Application (2021-2032)
Figure 57. North America Algae Based Omega-3 Sales Revenue (US$ Million) by Application (2021-2032)
Figure 58. US Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 59. Canada Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 60. Mexico Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 61. Europe Algae Based Omega-3 Sales YoY (MT), 2021-2032
Figure 62. Europe Algae Based Omega-3 Revenue YoY (US$ Million), 2021-2032
Figure 63. Europe Top 5 Manufacturers Algae Based Omega-3 Sales Revenue (US$ Million) in 2025
Figure 64. Europe Algae Based Omega-3 Sales Volume (MT) by Application (2021-2032)
Figure 65. Europe Algae Based Omega-3 Sales Revenue (US$ Million) by Application (2021-2032)
Figure 66. Germany Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 67. France Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 68. U.K. Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 69. Italy Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 70. Russia Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 71. Asia-Pacific Algae Based Omega-3 Sales YoY (MT), 2021-2032
Figure 72. Asia-Pacific Algae Based Omega-3 Revenue YoY (US$ Million), 2021-2032
Figure 73. Asia-Pacific Top 8 Manufacturers Algae Based Omega-3 Sales Revenue (US$ Million) in 2025
Figure 74. Asia-Pacific Algae Based Omega-3 Sales Volume (MT) by Application (2021-2032)
Figure 75. Asia-Pacific Algae Based Omega-3 Sales Revenue (US$ Million) by Application (2021-2032)
Figure 76. Indonesia Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 77. Japan Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 78. South Korea Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 79. China Taiwan Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 80. India Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 81. Central and South America Algae Based Omega-3 Sales YoY (MT), 2021-2032
Figure 82. Central and South America Algae Based Omega-3 Revenue YoY (US$ Million), 2021-2032
Figure 83. Central and South America Top 5 Manufacturers Algae Based Omega-3 Sales Revenue (US$ Million) in 2025
Figure 84. Central and South America Algae Based Omega-3 Sales Volume (MT) by Application (2021-2032)
Figure 85. Central and South America Algae Based Omega-3 Sales Revenue (US$ Million) by Application (2021-2032)
Figure 86. Brazil Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 87. Argentina Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 88. Middle East, and Africa Algae Based Omega-3 Sales YoY (MT), 2021-2032
Figure 89. Middle East and Africa Algae Based Omega-3 Revenue YoY (US$ Million), 2021-2032
Figure 90. Middle East and Africa Top 5 Manufacturers Algae Based Omega-3 Sales Revenue (US$ Million) in 2025
Figure 91. Middle East and Africa Algae Based Omega-3 Sales Volume (MT) by Application (2021-2032)
Figure 92. Middle East and Africa Algae Based Omega-3 Sales Revenue (US$ Million) by Application (2021-2032)
Figure 93. GCC Countries Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 94. Turkey Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 95. Egypt Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 96. South Africa Algae Based Omega-3 Revenue (US$ Million), 2021-2032
Figure 97. Algae Based Omega-3 Industry Chain Mapping
Figure 98. Regional Algae Based Omega-3 Manufacturing Base Distribution (%)
Figure 99. Algae Based Omega-3 Production Process
Figure 100. Regional Algae Based Omega-3 Production Cost Structure
Figure 101. Channels of Distribution (Direct Vs Distribution)
Figure 102. Bottom-up and Top-down Approaches for This Report
Figure 103. Data Triangulation
Figure 104. Key Executives Interviewed